LLY — Eli Lilly and Company · P/E 39, rev $22.97B

Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.

Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.

Use this LLY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LLY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LLY SEC filings page. Lician reads the product cache first so this HTML stays unique to Eli Lilly and Company even when a live quote feed is slow.

Eli Lilly and Company latest statements (FY2025)

Latest cached year on this hub. Full LLY income, balance, and cash tables.

  • Revenue$65.18B
  • Net Income$20.64B
  • Total Assets$112.48B
  • Total Debt$0
  • Free Cash Flow$0

LLY recent filings